It also aligns with a strategy that 23andMe had been pursuing for years. The Regeneron Biotechnology company logo is seen displayed on a smartphone. (Igor Golovniov/SOPA Images/LightRocket via ...

After a bankruptcy court and regulators sign off, Regeneron would acquire 23andMe’s signature Personal Genome Service, its Total Health and Research Services business lines and its biobank of ...